Announcements Trials
Browse Landscape

Phase

Phase 2 13Phase 1/2 7Phase 3 5

Status

Completed 22Recruiting 13Active not recruiting 9Terminated 6Unknown 5Withdrawn 4

Sponsor Class

OTHER 2INDUSTRY 2NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Lymphoid 4Other hematologic neoplasm 2Plasma cell 1

Conditions

Neoplasms 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, B-Cell 1Leukemia 1

Interventions

Cisplatin 130Radiotherapy 94Carboplatin 85Paclitaxel 78Fluorouracil 78Cyclophosphamide 77Gemcitabine 72Capecitabine 66Docetaxel 65Doxorubicin 60Oxaliplatin 59Etoposide 57Leucovorin 49Vincristine 47Chemotherapy, Adjuvant 42Cytarabine 38Dexamethasone 35Drug Therapy 33Bevacizumab 30Epirubicin 29Neoadjuvant Therapy 28Pemetrexed 27Tamoxifen 25Prednisone 24Irinotecan 24Rituximab 21Methotrexate 21Radiotherapy, Intensity-Modulated 19apatinib 18Vinorelbine 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Unknown × Bendamustine Hydrochloride × Clear all
NCT05006469 2021-08-16

Observation of the Efficacy of BAd Regimen in the Treatment of Relapsed and Refractory Multiple Myeloma

Shengjing Hospital

Phase 3 Unknown
10 enrolled
Plasma cell

Multiple Myeloma

NCT02423837 2015-04-22

BRiF

National Research Center for Hematology, Russia

Phase 3 Unknown
200 enrolled
Lymphoid

Lymphoma, Follicular

NCT01678430 2012-10-15

RIAltO

University of Liverpool

Phase 3 Unknown
670 enrolled
LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT01657955 2012-08-06

CLL

Shandong Lanjin Pharmaceuticals Co.,Ltd

Phase 3 Unknown
96 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01570049 2012-08-02

Safety and Efficacy Study of Bendamustine to Treat Non-Hodgkin Lymphoma

Shandong Lanjin Pharmaceuticals Co.,Ltd

Phase 3 Unknown
100 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡